{"id":"hypromellose","rwe":[],"_fda":{"id":"312ea999-0542-99ea-e063-6294a90ae29e","set_id":"00da365d-2988-9c9e-e063-6294a90a8931","openfda":{"unii":["B1QE5P712K"],"route":["OPHTHALMIC"],"spl_id":["312ea999-0542-99ea-e063-6294a90ae29e"],"brand_name":["Vista Gonio Eye Lubricant"],"spl_set_id":["00da365d-2988-9c9e-e063-6294a90a8931"],"package_ndc":["77790-022-15"],"product_ndc":["77790-022"],"generic_name":["HYPROMELLOSE OPHTHALMIC SOLUTION"],"product_type":["HUMAN OTC DRUG"],"substance_name":["HYPROMELLOSE 2208 (100 MPA.S)"],"manufacturer_name":["Red Wedding LLC"],"application_number":["M018"],"is_original_packager":[true]},"purpose":["Use For use as a lubricant to prevent further irritation or to relieve dryness of the eye."],"version":"4","stop_use":["Stop use and consult a physician if you experience any of the following: eye pain changes in vision occur irritation or redness for longer than 72 hours"],"warnings":["Warnngs For external use only Do not use ■ if this product changes color or becomes cloudy ■ if seal is broken or punctured When using this product ■ do not touch tip of container to any surface to avoid contamination ■ replace cap after each use Stop use and consult a physician if you experience any of the following ■ eye pain ■ changes in vision ■ irritation or redness for longer than 72 hours If pregnant or breast-feeding, ask a health professional before use. Do not use if this product changes color or becomes cloudy if you are sensitive to any ingredient in this product When using this product do not touch the tip of container to any surface to avoid contamination replace cap after each use Stop use and consult a physician if you experience any of the following: eye pain changes in vision occur irritation or redness for longer than 72 hours Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away If pregnant or breastfeeding ask a health professional before use."],"pregnancy":["If pregnant or breastfeeding ask a health professional before use."],"questions":["Questions? In the US Call 1-866-999-1497 Website: www.VistaOTC.com"],"do_not_use":["Do not use if this product changes color or becomes cloudy if you are sensitive to any ingredient in this product"],"when_using":["When using this product do not touch the tip of container to any surface to avoid contamination replace cap after each use"],"effective_time":"20250325","active_ingredient":["Active ingredients Hypromellose USP 2.5% w/v .....Lubricant"],"inactive_ingredient":["Inactive ingredients Edetate Disodium, Boric Acid, Sodium Borate, Potassium Chloride, Hydrochloric Acid and/or Sodium Hxydroxide may be added to adjust pH, Water for Injection. Preservative - Benzalkonium Chloride NF."],"indications_and_usage":["Uses for use as a lubricant to prevent further irritation to relieve dryness of the eye"],"other_safety_information":["Other information Store at room temperature 15-30 0 C(59-86 0 F). do not freeze. See box for complete information"],"dosage_and_administration":["Directions Instill 1 or 2 drops in the affected eye(s) as needed"],"spl_product_data_elements":["Vista Gonio Eye Lubricant Hypromellose Ophthalmic Solution HYDROCHLORIC ACID SODIUM BORATE BENZALKONIUM CHLORIDE BORIC ACID WATER EDETATE DISODIUM HYPROMELLOSE 2208 (100 MPA.S) HYPROMELLOSE 2208 (100 MPA.S) SODIUM HYDROXIDE POTASSIUM CHLORIDE"],"keep_out_of_reach_of_children":["Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away"],"package_label_principal_display_panel":["Vista Gonio - Box Vista Gonio - Label Vista Gonio Box 77790-022 Vista Gonio Label 77790-022-15"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Ophthalmic","category":"route"},{"label":"Active","category":"status"},{"label":"dryness of the eye","category":"indication"},{"label":"Red Wedding LLC","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"EYE IRRITATION","source":"FDA FAERS","actionTaken":"211 reports"},{"date":"","signal":"EYE PAIN","source":"FDA FAERS","actionTaken":"165 reports"},{"date":"","signal":"VISION BLURRED","source":"FDA FAERS","actionTaken":"147 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"131 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"116 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"114 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"112 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"108 reports"},{"date":"","signal":"OCULAR HYPERAEMIA","source":"FDA FAERS","actionTaken":"103 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"98 reports"}],"specialPopulations":{"Pregnancy":"If pregnant or breastfeeding ask a health professional before use."}},"trials":[],"aliases":[],"company":"Red Wedding LLC","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=HYPROMELLOSE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:17:55.183174+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Hypromellose","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:18:01.888600+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:00.647088+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=HYPROMELLOSE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:00.842544+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:53.910439+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:53.910490+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:18:02.363526+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108956/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:01.536529+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M018","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:53.910496+00:00"}},"allNames":"vista gonio eye lubricant","offLabel":[],"synonyms":["Vista Gonio Eye Lubricant","HYPROMELLOSE 2208 (100 MPA.S)"],"timeline":[],"approvals":[],"brandName":"Vista Gonio Eye Lubricant","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Hypromellose, the active ingredient in Vista Gonio Eye Lubricant, is a high molecular weight polysaccharide that forms a hydrophilic gel-like film on the surface of the eye, providing sustained hydration and lubrication."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Hypromellose","title":"Hypromellose","extract":"Hypromellose (INN), short for hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer used in eye drops, as well as an excipient and controlled-delivery component in oral medicaments, found in a variety of commercial products."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"HYPROMELLOSE\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=hypromellose","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=hypromellose","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Hypromellose","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-31T10:23:55.049053","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:03.645511+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"hypromellose","indications":{"approved":[{"name":"dryness of the eye","source":"OpenFDA Label","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03786796","phase":"PHASE2","title":"Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2019-06-03","conditions":["Renal Cell Carcinoma","Metastatic Renal Cell Carcinoma","Kidney Cancer","Renal Carcinoma","Kidney Cancer Metastatic"],"enrollment":20,"completionDate":"2028-03"},{"nctId":"NCT07240246","phase":"NA","title":"Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation","startDate":"2025-10-24","conditions":["GLP-1","Obesity &Amp; Overweight","Dietary Supplement"],"enrollment":40,"completionDate":"2026-05-11"},{"nctId":"NCT07495852","phase":"PHASE3","title":"Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2026-02-17","conditions":["Glaucoma"],"enrollment":510,"completionDate":"2032-03"},{"nctId":"NCT06299319","phase":"PHASE1","title":"Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-09-01","conditions":["Obsessive-Compulsive Disorder"],"enrollment":10,"completionDate":"2026-08"},{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":["Dry Eye Disease"],"enrollment":80,"completionDate":"2025-03-21"},{"nctId":"NCT07485959","phase":"NA","title":"The Effect of NP-2006 on Sleep Quality and Health","status":"COMPLETED","sponsor":"Hanpoong Nature Pharm Co., Ltd.","startDate":"2023-05-12","conditions":["Sleep Disorder (Disorder)"],"enrollment":48,"completionDate":"2025-08-13"},{"nctId":"NCT07243275","phase":"PHASE4","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-02-18","conditions":["Dry Eye Disease (DED)"],"enrollment":260,"completionDate":"2026-09-30"},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":["Recurrent Ovarian Cancer","Folate Receptor-Alpha Positive"],"enrollment":100,"completionDate":"2027-06"},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":["Trachomatous Trichiasis (TT)","Eye Diseases","Eyelid Diseases","Trachomatous","Trichiasis"],"enrollment":2410,"completionDate":"2024-11-30"},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":["Chronic Heart Failure"],"enrollment":40,"completionDate":"2026-11"},{"nctId":"NCT05319730","phase":"PHASE1,PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":["Esophageal Squamous Cell Carcinoma"],"enrollment":230,"completionDate":"2029-04-10"},{"nctId":"NCT07482085","phase":"PHASE3","title":"Efavirenz for the Treatment of Creutzfeldt-Jakob Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03","conditions":["Creutzfeldt-Jakob Disease"],"enrollment":246,"completionDate":"2028-12"},{"nctId":"NCT05577910","phase":"NA","title":"Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2022-10-08","conditions":["Meibomian Gland Dysfunction"],"enrollment":374,"completionDate":"2025-01-26"},{"nctId":"NCT06089317","phase":"NA","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-28","conditions":["Dry Eye Syndromes"],"enrollment":200,"completionDate":"2025-06-22"},{"nctId":"NCT02938520","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-27","conditions":["HIV Infections"],"enrollment":631,"completionDate":"2029-12-31"},{"nctId":"NCT06819046","phase":"","title":"Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment","status":"COMPLETED","sponsor":"Colorado Ophthalmology Associates PC","startDate":"2025-02-14","conditions":["Glaucoma"],"enrollment":70,"completionDate":"2025-12-17"},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":["Dry Eye Disease"],"enrollment":55,"completionDate":"2025-02-06"},{"nctId":"NCT06792903","phase":"EARLY_PHASE1","title":"YM-101 Eye Drops in the Treatment of Dry Eye Syndrome","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-04-23","conditions":["Dry Eye"],"enrollment":30,"completionDate":"2025-05-15"},{"nctId":"NCT07475299","phase":"NA","title":"Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Iuliu Hatieganu University of Medicine and Pharmacy","startDate":"2026-04","conditions":["Irritable Bowel Syndrome (IBS)"],"enrollment":8,"completionDate":"2027-01"},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":["Meibomian Gland Dysfunction (MGD)"],"enrollment":48,"completionDate":"2027-02-01"},{"nctId":"NCT07469865","phase":"NA","title":"Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-11-30","conditions":["Dry Eye Disease"],"enrollment":46,"completionDate":"2025-12-30"},{"nctId":"NCT07471048","phase":"NA","title":"A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis","status":"RECRUITING","sponsor":"Sirt3 LLC","startDate":"2026-03-01","conditions":["Psoriasis"],"enrollment":100,"completionDate":"2029-09-01"},{"nctId":"NCT07471659","phase":"NA","title":"Effect of Daily Humiome® Post LB Intake on Wellbeing in Older Individuals With Moderate Stress Levels","status":"NOT_YET_RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2026-03-01","conditions":["Stress"],"enrollment":200,"completionDate":"2026-12"},{"nctId":"NCT07284381","phase":"PHASE3","title":"A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-12-15","conditions":["Dry Eye Disease"],"enrollment":250,"completionDate":"2026-11"},{"nctId":"NCT07463950","phase":"PHASE4","title":"A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2026-01-20","conditions":["Dry Eye Disease (DED)"],"enrollment":25,"completionDate":"2027-01"},{"nctId":"NCT03875820","phase":"PHASE1","title":"Phase I Trial of Defactinib and VS-6766.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2017-12-12","conditions":["NSCLC","Low Grade Serous Ovarian Cancer","Endometrioid Carcinoma","Pancreatic Cancer"],"enrollment":87,"completionDate":"2026-10-31"},{"nctId":"NCT05425004","phase":"PHASE2","title":"Cabozantinib for Patients With Recurrent or Progressive Meningioma","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2022-06-01","conditions":["Meningioma"],"enrollment":24,"completionDate":"2028-05"},{"nctId":"NCT05692739","phase":"PHASE4","title":"Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye","status":"COMPLETED","sponsor":"Barbara Burgos Blasco","startDate":"2022-10-19","conditions":["Dry Eye","Insulin"],"enrollment":116,"completionDate":"2025-11-05"},{"nctId":"NCT07075718","phase":"PHASE2,PHASE3","title":"Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2025-06-12","conditions":["Glaucoma"],"enrollment":610,"completionDate":"2032-03"},{"nctId":"NCT07371169","phase":"NA","title":"Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance","status":"COMPLETED","sponsor":"Uruk University","startDate":"2025-01-01","conditions":["Insulin Resistance","Acanthosis Nigricans"],"enrollment":90,"completionDate":"2026-01-01"},{"nctId":"NCT07109869","phase":"PHASE3","title":"Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis","status":"RECRUITING","sponsor":"pH-D Feminine Health LLC","startDate":"2025-08-08","conditions":["Vulvovaginal Candidiases","Vulvovaginal Candidiasis, Genital","Vulvovaginal Candidiasis (VVC)"],"enrollment":400,"completionDate":"2026-06"},{"nctId":"NCT06637423","phase":"PHASE1,PHASE2","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-20","conditions":["Non-Muscle Invasive Bladder Cancer"],"enrollment":32,"completionDate":"2028-07-31"},{"nctId":"NCT07422259","phase":"NA","title":"Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed","status":"COMPLETED","sponsor":"Medivis SRL","startDate":"2025-06-09","conditions":["Keratoconjunctivitis Sicca"],"enrollment":40,"completionDate":"2025-09-03"},{"nctId":"NCT06425094","phase":"NA","title":"Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2024-02-05","conditions":["Gastrointestinal Problem","Anxiety","Stress","Gastrointestinal Symptoms"],"enrollment":62,"completionDate":"2025-01-31"},{"nctId":"NCT06271564","phase":"EARLY_PHASE1","title":"Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-02-29","conditions":["Oral Potentially Malignant Lesions"],"enrollment":20,"completionDate":"2026-12-30"},{"nctId":"NCT07413172","phase":"PHASE2","title":"Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-03","conditions":["Dry Eye","Eye Diseases","Eyes Dry Chronic"],"enrollment":20,"completionDate":"2028-03"},{"nctId":"NCT07411482","phase":"NA","title":"The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2023-12-01","conditions":["Intestinal Microbiome","Probiotic","Runners"],"enrollment":27,"completionDate":"2026-03"},{"nctId":"NCT06045494","phase":"NA","title":"The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21","status":"COMPLETED","sponsor":"Meiji China Investment Co.,Ltd","startDate":"2023-09-26","conditions":["H. Pylori Infection"],"enrollment":140,"completionDate":"2024-01-30"},{"nctId":"NCT06631586","phase":"PHASE2","title":"Standardized Microbiota Transplant Therapy in Crohn's Disease","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-01-15","conditions":["Crohn Disease"],"enrollment":120,"completionDate":"2029-06-15"},{"nctId":"NCT07264517","phase":"PHASE2","title":"Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).","status":"RECRUITING","sponsor":"Instituto Grifols, S.A.","startDate":"2025-11-03","conditions":["Dry Eye Disease"],"enrollment":100,"completionDate":"2026-11-14"},{"nctId":"NCT03843385","phase":"PHASE3","title":"Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","status":"RECRUITING","sponsor":"Andreas Stallmach","startDate":"2023-01-31","conditions":["Ulcerative Colitis","Inflammatory Bowel Diseases"],"enrollment":129,"completionDate":"2027-04"},{"nctId":"NCT07408297","phase":"PHASE2","title":"Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda","status":"COMPLETED","sponsor":"Victoria Biomedical Research Institute","startDate":"2022-05-18","conditions":["COVID -19","SARS CoV 2 Infection"],"enrollment":1919,"completionDate":"2024-06-27"},{"nctId":"NCT06859476","phase":"PHASE4","title":"Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2025-05-23","conditions":["Ophthalmological Agent Toxicity"],"enrollment":168,"completionDate":"2025-09-23"},{"nctId":"NCT07388576","phase":"NA","title":"A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Younger Adults With Self-reported Attention Problems","status":"NOT_YET_RECRUITING","sponsor":"Rousselot BVBA","startDate":"2026-03","conditions":["Cognition","Cognitive Function"],"enrollment":120,"completionDate":"2026-05"},{"nctId":"NCT07388043","phase":"NA","title":"A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Middle-aged and Older Adults With Self-reported Memory Problems","status":"NOT_YET_RECRUITING","sponsor":"Rousselot BVBA","startDate":"2026-03","conditions":["Cognition","Cognitive Function"],"enrollment":120,"completionDate":"2026-05"},{"nctId":"NCT07382453","phase":"PHASE2","title":"Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2026-02-15","conditions":["Diabetic Keratopathy"],"enrollment":30,"completionDate":"2029-06-30"},{"nctId":"NCT07041814","phase":"PHASE2","title":"A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases","status":"NOT_YET_RECRUITING","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2026-02-15","conditions":["Turner Syndrome"],"enrollment":24,"completionDate":"2029-10-31"},{"nctId":"NCT06213649","phase":"PHASE3","title":"Parasitic Ulcer Treatment Trial","status":"RECRUITING","sponsor":"Jeremy Keenan, MD, MPH","startDate":"2024-07-01","conditions":["Acanthamoeba Keratitis"],"enrollment":232,"completionDate":"2028-07"},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":["Atropine Bioequivalence"],"enrollment":46,"completionDate":"2024-05-22"},{"nctId":"NCT05414994","phase":"","title":"Assessment of the Ocular Microbiome in Health and Disease","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-09-07","conditions":["Microbial Colonization","Eye Diseases","Ophthalmopathy"],"enrollment":500,"completionDate":"2027-12-30"},{"nctId":"NCT06428409","phase":"PHASE1,PHASE2","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-20","conditions":["Colorectal Cancer","Pancreatic Ductal Adenocarcinoma","Biliary Tract Cancer"],"enrollment":220,"completionDate":"2029-10-16"},{"nctId":"NCT05230758","phase":"PHASE3","title":"Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour","status":"RECRUITING","sponsor":"Donald Mabbott","startDate":"2022-07-01","conditions":["Medulloblastoma, Childhood","Cognitive Impairment"],"enrollment":140,"completionDate":"2027-11-30"},{"nctId":"NCT06163989","phase":"NA","title":"Protecting the Eyes of Gamers With Lubricating Eyedrops","status":"RECRUITING","sponsor":"Aston University","startDate":"2024-09-01","conditions":["Dry Eye Syndromes","Computer Vision Syndrome"],"enrollment":28,"completionDate":"2026-12-30"},{"nctId":"NCT04505566","phase":"PHASE1","title":"INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen J. Kim, MD","startDate":"2020-11-09","conditions":["Diabetic Retinopathy"],"enrollment":164,"completionDate":"2026-05"},{"nctId":"NCT07271316","phase":"PHASE2","title":"Alii Supplement Study","status":"RECRUITING","sponsor":"Texas Christian University","startDate":"2026-01-12","conditions":["Nutrient Deficiency","Happiness","Digestive Health","Vulnerability to Disease","Mood Swings","Energy"],"enrollment":68,"completionDate":"2026-04-29"},{"nctId":"NCT03697876","phase":"PHASE1","title":"Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-08-20","conditions":["Dry Eye Syndromes"],"enrollment":32,"completionDate":"2024-06-26"},{"nctId":"NCT03471143","phase":"PHASE1,PHASE2","title":"Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-02-22","conditions":["Niemann-Pick Disease, Type C"],"enrollment":4,"completionDate":"2024-10-04"},{"nctId":"NCT02951052","phase":"PHASE3","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-28","conditions":["Infection, Human Immunodeficiency Virus","HIV Infections"],"enrollment":618,"completionDate":"2029-12-31"},{"nctId":"NCT06227858","phase":"NA","title":"Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated With Perimenopause in Healthy Women","status":"RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-08-20","conditions":["Perimenopausal Disorder"],"enrollment":104,"completionDate":"2026-03-31"},{"nctId":"NCT05265091","phase":"PHASE1,PHASE2","title":"A Study of KL590586 in Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.","startDate":"2021-09-15","conditions":["Advanced Solid Tumor"],"enrollment":414,"completionDate":"2026-12-31"},{"nctId":"NCT06308653","phase":"PHASE3","title":"Psilocybin for Major Depressive Disorder (MDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Usona Institute","startDate":"2024-03-13","conditions":["Depressive Disorder, Major"],"enrollment":240,"completionDate":"2026-12-30"},{"nctId":"NCT05632562","phase":"EARLY_PHASE1","title":"Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2024-03-07","conditions":["High Grade Glioma"],"enrollment":20,"completionDate":"2028-02-01"},{"nctId":"NCT05106127","phase":"PHASE2","title":"Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem","status":"NOT_YET_RECRUITING","sponsor":"Evergreen Therapeutics, Inc.","startDate":"2026-08","conditions":["Advanced Endometrial Cancer"],"enrollment":28,"completionDate":"2027-03"},{"nctId":"NCT06736366","phase":"NA","title":"Study With Two Coenzyme Q10 Products","status":"COMPLETED","sponsor":"University of Primorska","startDate":"2024-12-05","conditions":["Coenzyme Q Deficiency"],"enrollment":25,"completionDate":"2025-06-30"},{"nctId":"NCT06223685","phase":"NA","title":"The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin","status":"COMPLETED","sponsor":"Pomeranian Medical University Szczecin","startDate":"2023-04-01","conditions":["Irritable Bowel Syndrome","Small Intestinal Bacterial Overgrowth","SIBO"],"enrollment":129,"completionDate":"2025-08-30"},{"nctId":"NCT05249556","phase":"PHASE3","title":"Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old","status":"NOT_YET_RECRUITING","sponsor":"Immedica Pharma AB","startDate":"2026-06","conditions":["CDKL5 Deficiency Disorder"],"enrollment":20,"completionDate":"2028-09"},{"nctId":"NCT06815653","phase":"PHASE1","title":"Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs","status":"RECRUITING","sponsor":"University College, London","startDate":"2025-03-01","conditions":["Healthy"],"enrollment":40,"completionDate":"2026-12"},{"nctId":"NCT06489340","phase":"PHASE2","title":"P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease","status":"WITHDRAWN","sponsor":"ZyVersa Therapeutics, Inc.","startDate":"2025-06-11","conditions":["Diabetic Kidney Disease"],"enrollment":0,"completionDate":"2026-08-11"},{"nctId":"NCT06968299","phase":"NA","title":"Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological","status":"RECRUITING","sponsor":"SunWay Biotech Co., LTD.","startDate":"2025-05-20","conditions":["Cognitive Functions Perceptual Disturbances","Cognitive Function Abnormal","Sleep","Psychological"],"enrollment":50,"completionDate":"2025-12-30"},{"nctId":"NCT07234318","phase":"","title":"Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears","status":"NOT_YET_RECRUITING","sponsor":"Laboratoires Thea","startDate":"2025-12-15","conditions":["Dry Eye Disease (DED)"],"enrollment":25,"completionDate":"2026-06-30"},{"nctId":"NCT06886373","phase":"PHASE4","title":"Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-03-25","conditions":["Ophthalmology"],"enrollment":140,"completionDate":"2027-12-31"},{"nctId":"NCT05185583","phase":"PHASE2","title":"Methylphenidate in Childhood Apraxia of Speech","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-03-14","conditions":["Childhood Apraxia of Speech"],"enrollment":18,"completionDate":"2025-10-27"},{"nctId":"NCT06834984","phase":"NA","title":"Ritual Synbiotic+, a Dietary Supplement Designed to Impact Gastrointestinal Health, Mood, and Behavior in Women","status":"RECRUITING","sponsor":"Colorado State University","startDate":"2025-05-01","conditions":["Gastrointestinal Disease Symptoms"],"enrollment":60,"completionDate":"2025-12-31"},{"nctId":"NCT07229001","phase":"NA","title":"Treating Meibomian Gland Disease in a Pediatric Population","status":"ENROLLING_BY_INVITATION","sponsor":"Illinois College of Optometry","startDate":"2024-10-01","conditions":["Dry Eye Disease, Meibomian Gland Disease"],"enrollment":15,"completionDate":"2026-12-30"},{"nctId":"NCT02118922","phase":"","title":"A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2013-06","conditions":["Keratoconus","Ectasia","Crosslinking","Fuchs' Endothelial Dystrophy"],"enrollment":168,"completionDate":"2026-09"},{"nctId":"NCT04968912","phase":"PHASE2","title":"A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-21","conditions":["Sjogren's Syndrome"],"enrollment":163,"completionDate":"2023-11-30"},{"nctId":"NCT05031897","phase":"PHASE2","title":"Two Step Haplo With Radiation Conditioning","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2021-10-25","conditions":["Acute Lymphoblastic Leukemia","Acute Myeloid Leukemia","Adult T-Cell Leukemia/Lymphoma","Aplastic Anemia","Chronic Lymphocytic Leukemia","Chronic Myeloid Leukemia, BCR-ABL1 Positive","Chronic Myelomonocytic Leukemia","Essential Thrombocythemia","Hematopoietic and Lymphatic System Neoplasm","Hodgkin Lymphoma","Multiple Myeloma","Myelodysplastic Syndrome","Myelofibrosis","Myeloid Neoplasm","Non-Hodgkin Lymphoma","Polycythemia Vera","Small Lymphocytic Lymphoma"],"enrollment":63,"completionDate":"2032-04"},{"nctId":"NCT01760655","phase":"PHASE2","title":"Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2012-12-24","conditions":["Acute Myeloid Leukemia With FLT3/ITD Mutation","Acute Myeloid Leukemia With Gene Mutations","Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM","Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214","Aplastic Anemia","Chronic Lymphocytic Leukemia","Chronic Myelogenous Leukemia, BCR-ABL1 Positive","Chronic Myelomonocytic Leukemia","Follicular Lymphoma","Hodgkin Lymphoma","Myelodysplastic Syndrome","Myelofibrosis","Myeloid Leukemia","Non-Hodgkin Lymphoma","Plasma Cell Myeloma","Polycythemia Vera","Recurrent Adult Acute Myeloid Leukemia","Recurrent Childhood Acute Myeloid Leukemia","Refractory Acute Myeloid Leukemia","Secondary Acute Myeloid Leukemia","Therapy-Related Acute Myeloid Leukemia"],"enrollment":62,"completionDate":"2022-12-05"},{"nctId":"NCT05999630","phase":"PHASE3","title":"Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-08-21","conditions":["Nasolacrimal Duct Obstruction","Thyroid Cancer"],"enrollment":100,"completionDate":"2027-12-31"},{"nctId":"NCT07078955","phase":"PHASE2","title":"A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"BRIM Biotechnology Inc.","startDate":"2025-12","conditions":["Dry Eye Disease (DED)","Keratoconjunctivitis Sicca"],"enrollment":99,"completionDate":"2027-03"},{"nctId":"NCT07215351","phase":"NA","title":"Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women","status":"RECRUITING","sponsor":"University of Memphis","startDate":"2025-10-07","conditions":["Constipation","Bloating"],"enrollment":30,"completionDate":"2026-01-01"},{"nctId":"NCT05800353","phase":"NA","title":"Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters","status":"COMPLETED","sponsor":"Dongyang People's Hospital","startDate":"2022-11-22","conditions":["Weiss Ring"],"enrollment":70,"completionDate":"2024-12-31"},{"nctId":"NCT04440280","phase":"PHASE2","title":"Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2020-09-16","conditions":["Fuchs Endothelial Corneal Dystrophy"],"enrollment":45,"completionDate":"2027-04-30"},{"nctId":"NCT06227052","phase":"PHASE4","title":"Applying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2024-02-05","conditions":["Pain With Paracervical Block","Pain With Gynecology Procedure","Pain"],"enrollment":98,"completionDate":"2025-03-07"},{"nctId":"NCT07181668","phase":"NA","title":"Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery","status":"COMPLETED","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2024-08-10","conditions":["Dry Eye","Meibomian Gland Dysfunction (Disorder)","Ocular Surface Disease"],"enrollment":61,"completionDate":"2025-07-30"},{"nctId":"NCT06191965","phase":"PHASE2,PHASE3","title":"MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-06-01","conditions":["Schizophrenia and Related Disorders","Mitochondrial Alteration","Cognitive Impairment"],"enrollment":100,"completionDate":"2027-01-31"},{"nctId":"NCT06876077","phase":"NA","title":"Evaluation of the Effectiveness of Auricular Acupuncture in Improving Dry Eye Symptoms in University Students","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2025-03-15","conditions":["Dry Eye Symptoms"],"enrollment":50,"completionDate":"2025-08-31"},{"nctId":"NCT07185854","phase":"NA","title":"Medical vs Acupuncture for Dry Eye","status":"COMPLETED","sponsor":"Nadide Koca","startDate":"2024-01-15","conditions":["Dry Eye","Acupuncture"],"enrollment":90,"completionDate":"2025-08-01"},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":["Dry Eye"],"enrollment":36,"completionDate":"2025-07-31"},{"nctId":"NCT05542381","phase":"NA","title":"The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2022-12-22","conditions":["Age-Related Macular Degeneration"],"enrollment":64,"completionDate":"2025-05-01"},{"nctId":"NCT07165977","phase":"NA","title":"Anti-inflammatory Probiotics in Cognitive Functioning","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Social Sciences and Humanities, Warsaw","startDate":"2024-01-25","conditions":["Memory Decline","Cognitive Decline","Cognitive Aging"],"enrollment":110,"completionDate":"2026-12-31"},{"nctId":"NCT07145827","phase":"NA","title":"Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen","status":"COMPLETED","sponsor":"Uruk University","startDate":"2024-01-02","conditions":["Breast Cancer","Endometrial Hyperplasia and Endometrial Cancers"],"enrollment":60,"completionDate":"2025-07-01"},{"nctId":"NCT06911073","phase":"NA","title":"A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health","status":"RECRUITING","sponsor":"ResBiotic Nutrition, Inc.","startDate":"2025-05-02","conditions":["Obesity and Overweight"],"enrollment":80,"completionDate":"2025-12"},{"nctId":"NCT05938699","phase":"PHASE2,PHASE3","title":"Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution","status":"COMPLETED","sponsor":"Nicox Ophthalmics, Inc.","startDate":"2023-12-12","conditions":["Open Angle Glaucoma"],"enrollment":18,"completionDate":"2025-03-17"},{"nctId":"NCT05737342","phase":"NA","title":"Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose","status":"RECRUITING","sponsor":"SunWay Biotech Co., LTD.","startDate":"2023-04-01","conditions":["High Blood Sugar","Metabolic Syndrome"],"enrollment":80,"completionDate":"2025-10-31"},{"nctId":"NCT05737355","phase":"NA","title":"Effect of ANKASCIN 568-P Products Regulating Blood Lipid","status":"RECRUITING","sponsor":"SunWay Biotech Co., LTD.","startDate":"2023-04-01","conditions":["Hyperlipidemias"],"enrollment":80,"completionDate":"2025-10-31"},{"nctId":"NCT03712878","phase":"PHASE2","title":"2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2018-09-19","conditions":["Hematopoietic and Lymphoid Cell Neoplasm"],"enrollment":10,"completionDate":"2025-03-19"},{"nctId":"NCT06676917","phase":"PHASE2","title":"Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases","status":"WITHDRAWN","sponsor":"MedSIR","startDate":"2025-06","conditions":["Non-small Cell Lung Cancer"],"enrollment":0,"completionDate":"2027-08"},{"nctId":"NCT04585984","phase":"NA","title":"Effect of Antioxidant Probiotic Administration on Seminal Quality and Reproductive Outcomes.","status":"COMPLETED","sponsor":"Fundación IVI","startDate":"2021-02-05","conditions":["Male Infertility"],"enrollment":56,"completionDate":"2024-11-14"},{"nctId":"NCT07110467","phase":"NA","title":"Nursing Intervention of Blinking Exercises to Alleviate Dry Eye and Enhance Daily Life in Older Adults","status":"COMPLETED","sponsor":"Norther Private Collage of Nursing","startDate":"2024-11-01","conditions":["Daily Activities","Eye Health"],"enrollment":100,"completionDate":"2025-06-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Ophthalmic"},"crossReferences":{"UNII":"B1QE5P712K","SPL_ID":"312ea999-0542-99ea-e063-6294a90ae29e","chemblId":"CHEMBL2108956"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Red Wedding LLC","relationship":"Original Developer"}],"publicationCount":549,"therapeuticAreas":["Ophthalmology"],"biosimilarFilings":[],"originalDeveloper":"Red Wedding LLC","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Red Wedding LLC","companyId":"red-wedding-llc","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:03.645511+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}